The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

被引：0
|
作者：
Johanna Maffey-Steffan
Lorenza Scarpa
Anna Svirydenka
Bernhard Nilica
Christian Mair
Sabine Buxbaum
Jasmin Bektic
Elisabeth von Guggenberg
Christian Uprimny
Wolfgang Horninger
Irene Virgolini
机构：
[1] Medical University Innsbruck,Department of Nuclear Medicine
[2] Medical University Innsbruck,Department of Urology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2020年 / 47卷
关键词：
Lu-PSMA-617; Metastasized castration; resistant prostate cancer; Dosimetry; Post-therapy whole-body scintigraphy; Ga-PSMA-11; Theragnostic concept;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：695 / 712
页数：17
相关论文
共 50 条
  • [1] The 68Ga / 177Lu-Theragnostic Concept in PSMA-Targeting of Metastatic Castration Resistant Prostate Cancer: Impact of Post-therapeutic Whole Body Scintigraphy in the Follow-Up
    Scarpa, L.
    Maffey-Steffan, J.
    Svirydenka, A.
    Nilica, B.
    Buxbaum, S.
    Mair, C.
    Bektic, J.
    von Guggenberg, E.
    Uprimny, C.
    Horninger, W.
    Virgolini, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S649 - S649
  • [2] Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
    Johanna Maffey-Steffan
    Lorenza Scarpa
    Anna Svirydenka
    Bernhard Nilica
    Christian Mair
    Sabine Buxbaum
    Jasmin Bektic
    Elisabeth von Guggenberg
    Christian Uprimny
    Wolfgang Horninger
    Irene Virgolini
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 740 - 740
  • [3] The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
    Maffey-Steffan, Johanna
    Scarpa, Lorenza
    Svirydenka, Anna
    Bernhard, Nilica
    Mair, Christian
    Buxbaum, Sabine
    Bektic, Jasmin
    von Guggenberg, Elisabeth
    Uprimny, Christian
    Horninger, Wolfgang
    Virgolini, Irene
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 695 - 712
  • [4] The 68Ga/177Lu-Theragnostic Concept in PSMA-Targeting of Prostate Cancer: A Long( er) Way to Go?
    Scarpa, L.
    Buxbaum, S.
    Kendler, D.
    Bektic, J.
    Decristoforo, C.
    Gruber, L.
    Geraldo-Roig, L.
    Nilica, B.
    Uprimny, C.
    Fink, K.
    Lukas, P.
    Horninger, W.
    Virgolini, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S413 - S413
  • [5] The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates
    Lorenza Scarpa
    Sabine Buxbaum
    Dorota Kendler
    Katharina Fink
    Jasmin Bektic
    Leonhard Gruber
    Clemens Decristoforo
    Christian Uprimny
    Peter Lukas
    Wolfgang Horninger
    Irene Virgolini
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 788 - 800
  • [6] The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates
    Scarpa, Lorenza
    Buxbaum, Sabine
    Kendler, Dorota
    Fink, Katharina
    Bektic, Jasmin
    Gruber, Leonhard
    Decristoforo, Clemens
    Uprimny, Christian
    Lukas, Peter
    Horninger, Wolfgang
    Virgolini, Irene
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (05) : 788 - 800
  • [7] Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer
    Yadav, Madhav P.
    Ballal, Sanjana
    Tripathi, Madhavi
    Damle, Nishikant A.
    Sahoo, Ranjit K.
    Seth, Amlesh
    Bal, Chandrasekhar
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (01) : 91 - 98
  • [8] Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in treatment of patients with castration resistant prostate cancer
    Yadav, Madhav
    Ballal, Sanjana
    Tripathi, Madhavi
    Damle, Nishikant
    Sahoo, Ranjit
    Roesch, Frank
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [9] Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [68Ga]Ga/[177Lu]Lu-NYM032 for theranostic use in prostate cancer
    Fu, Haitian
    He, Huihui
    Wang, Yanjuan
    Li, Wenjin
    Luo, Yihui
    Chen, Liping
    Mi, Yuanyuan
    Sun, Chengwen
    Mao, Yong
    Yu, Chunjing
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, : 1671 - 1684
  • [10] 177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer
    Fendler, Wolfgang P.
    Kratochwil, Clemens
    Ahmadzadehfar, Hojjat
    Rahbar, Kambiz
    Baum, Richard P.
    Schmidt, Matthias
    Pfestroff, Andreas
    Luetzen, Ulf
    Prasad, Vikas
    Heinzel, Alexander
    Heuschkel, Martin
    Ruf, Juri
    Bartenstein, Peter
    Krause, Bernd J.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2016, 55 (03): : 123 - 128
12345